CLSA Advocates for Biomedical Innovation on Capitol Hill at the BIO Fly-In
April 20, 2018
By Adam Lotspike
This month, CLSA’s Washington, D.C.-based Federal Government Relations team participated in the annual BIO Fly-In to advocate for biomedical innovation, investment, and job creation in California. CLSA took part in a total of 18 meetings with bipartisan legislators on Capitol Hill, and had the privilege of presenting 7 members of our congressional delegation with 2018 BIO “Innovator in Biotechnology” awards, for their leadership in supporting biotech innovation. This year’s award winners included California Reps. Tony Cárdenas (D-San Fernando Valley), Jim Costa (D-Fresno/Merced), Anna G. Eshoo (D-Silicon Valley), Jimmy Panetta (D-Monterey), Scott Peters (D-San Diego), David Valadao (R-Hanford), and Mimi Walters (R-Irvine).
CLSA, along with representatives from executives of California innovator companies and other California regional life sciences associations, also met with Reps. Judy Chu (D-Pasadena), and Jimmy Gomez (D-Los Angeles), as well as staff members from the offices of Majority Leader Kevin McCarthy (R-Bakersfield), Democratic Leader Nancy Pelosi (D-San Francisco), and Reps. Doris Matsui (D-Sacramento), Devin Nunes (R-Clovis), Raul Ruiz, MD (D-Palm Desert), Linda Sanchez (D-Cerritos), Mike Thompson (D-Napa), and Sens. Dianne Feinstein (D) and Kamala Harris (D).
Discussions were focused around the importance of supporting basic research and workforce development, encouraging biomedical innovation as a means for combatting the opioid crisis, encouraging renewal of the Pandemic and All-Hazards Preparedness Act (PAHPA) and proper funding of biodefense and pandemic preparedness priorities, and improving coverage and payment policies to encourage and reward innovation and value.